VivoSeq
Other

Herbal Medicine

0

Pipeline Programs

1

Active Trials

1

Companies Involved

Herbal Medicine is an early-stage landscape with 0 programs across 1 company. The most active players are Shineway Pharmaceutical Co.,Ltd.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

8/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

12

clinical trials

Completed5 · 42%
Unknown status5 · 42%
Withdrawn1 · 8%
Not yet recruiting1 · 8%

Trial Activity

12 trials

A Chinese Herbal Medicine for IBS-C
Not yet recruiting·HHong Kong Baptist University·Phase 2·NCT06319729·78 enrolled
Cardiovascular-Protective Effects of Herbal Medicine Danshen-Gegen
Completed··Phase 2·NCT01033630·90 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)